Danaher 2010 third quarter Sales increases 16% to $3.2 billion

Danaher Corporation (NYSE: DHR) announced today that GAAP net earnings for the quarter ended October 1, 2010 were $646.4 million, or $0.95 per diluted share, which includes a $0.34 gain related to the formation of the Apex Tool Group joint venture, and represents a 79% increase as compared to GAAP net earnings per diluted share of $0.53 for the third quarter 2009. On a non-GAAP basis, which reflects the adjustments identified in the attached reconciliation schedule, 2010 third quarter adjusted net earnings were $405.4 million, or $0.60 per diluted share, a 33% increase over 2009 third quarter adjusted net earnings per diluted share of $0.45.  Sales for the 2010 third quarter were $3.2 billion, 16% higher than the $2.8 billion reported for the 2009 third quarter.  Core revenues increased 12.5% in the quarter compared to the third quarter of 2009.

GAAP net earnings for the first nine months of 2010 were $1.3 billion, or $1.95 per diluted share, compared with GAAP net earnings of $885 million, or $1.33 per diluted share for the first nine months of 2009. Sales for the first nine months of 2010 were $9.6 billion compared to $8.1 billion for the first nine months of 2009, an increase of 19%.

H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, "We saw sustained momentum across our businesses and were particularly pleased with our team's execution which led to outstanding year-over-year core margin expansion and earnings performance.  We're winning in the marketplace and serving our customers well with a continued focus on new product development and other organic initiatives that helped deliver outstanding core growth in the quarter.  We're confident that these growth investments as well as ample strategic acquisition opportunities will allow us to perform well for the remainder of 2010 and beyond."

Posted in:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Danaher. (2019, June 20). Danaher 2010 third quarter Sales increases 16% to $3.2 billion. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/news/20101021/Danaher-2010-third-quarter-Sales-increases-1625-to-2432-billion.aspx.

  • MLA

    Danaher. "Danaher 2010 third quarter Sales increases 16% to $3.2 billion". News-Medical. 18 April 2024. <https://www.news-medical.net/news/20101021/Danaher-2010-third-quarter-Sales-increases-1625-to-2432-billion.aspx>.

  • Chicago

    Danaher. "Danaher 2010 third quarter Sales increases 16% to $3.2 billion". News-Medical. https://www.news-medical.net/news/20101021/Danaher-2010-third-quarter-Sales-increases-1625-to-2432-billion.aspx. (accessed April 18, 2024).

  • Harvard

    Danaher. 2019. Danaher 2010 third quarter Sales increases 16% to $3.2 billion. News-Medical, viewed 18 April 2024, https://www.news-medical.net/news/20101021/Danaher-2010-third-quarter-Sales-increases-1625-to-2432-billion.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Molecular Devices brand re-launched into life sciences marketplace